IMVIQ
IMV Inc

3,604
Loading...
Loading...
IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of IMV Inc?
What is the 52-week high for IMV Inc?
What is the 52-week low for IMV Inc?
What is IMV Inc stock price today?
What is the 50-day moving average of IMV Inc?

Latest IMVIQ News

View
No IMVIQ news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.